DAVIS MELLICK: Open Payments
NPI 1407165236 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 17 payments from 9 companies in 2025. Trend: 2023 $455 · 2024 $451 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $106 |
| Globus Medical, Inc. | 2 | $76 |
| Corcept Therapeutics | 3 | $62 |
| Novo Nordisk Inc | 3 | $62 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Senza, Korlym, Wegovy, VRAYLAR, QULIPTA, SPRAVATO, FARXIGA, GARDASIL 9.
Industry payments across GA — which companies pay providers there.
